ABEONA THERAPEUTICS INC. (20)

Browse by Contract Category

Contracts

Letter Agreement, dated October 26, 2020, between Abeona Therapeutics Inc. and Michael Amoroso (Filed With SEC on October 30, 2020)
Form of Indemnification Agreement (Filed With SEC on October 16, 2020)
Description of Capital Stock of Abeona Therapeutics Inc (Filed With SEC on March 16, 2020)
First Amendment to License Agreement, dated November 1, 2019, between the Company and REGENXBIO Inc (Filed With SEC on November 12, 2019)
Amendment No. 3, dated April 14, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh (Filed With SEC on August 10, 2020)
Offer Letter between Abeona Therapeutics Inc. and Edward Carr, dated June 18, 2020 (Filed With SEC on June 23, 2020)
Amendment No. 2, dated March 31, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh (Filed With SEC on May 6, 2020)
Letter Agreement, dated March 13, 2020, between the Company and Christine Berni Silverstein (Filed With SEC on May 6, 2020)
Amendment No. 1, dated March 6, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh (Filed With SEC on May 6, 2020)
Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh (Filed With SEC on May 6, 2020)
Offer Letter, dated April 15, 2020, between Abeona Therapeutics Inc. and Brian J.G. Pereira, M.D (Filed With SEC on April 21, 2020)
Letter Agreement regarding Certain Purchaser Rights, dated December 20, 2019, among the Company, Biomedical Value Fund, L.P., Biomedical Offshore Value Fund, Ltd., and GEF-SMA, L.P (Filed With SEC on December 23, 2019)
Form of Pre-Funded Warrant (Filed With SEC on December 23, 2019)
Underwriting Agreement, dated December 20, 2019, among the Company, Jefferies LLC and SVB Leerink LLC (Filed With SEC on December 23, 2019)
Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Edward Carr, dated November 9, 2018 (Filed With SEC on November 12, 2019)
Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Christine Berni Silverstein, dated January 8, 2019 (Filed With SEC on November 12, 2019)
Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Joo Siffert, M.D., dated February 11, 2019 (Filed With SEC on November 12, 2019)
License Agreement, dated November 4, 2018, between the Company and REGENXBIO Inc (Filed With SEC on March 18, 2019)
Offer Letter, dated February 11, 2019, by and between Abeona Therapeutics Inc. and Joo Siffert, M.D (Filed With SEC on February 13, 2019)
Offer Letter, dated January 8, 2019, by and between Abeona Therapeutics Inc. and Christine Berni Silverstein (Filed With SEC on January 10, 2019)